Pharmacy

Pharmaceutical companies are strategizing how to muzzle Medicare's future power to negotiate drug prices, The Wall Street Journal reported Oct. 20. 

HHS will investigate whether retail pharmacies, including Walgreens and CVS, have complied with federal law since the Supreme Court's overturn of Roe v. Wade has sent shockwaves in pharmacies for the past four months. 

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

In a rare move, an advisory FDA panel voted 14-1 Oct. 19 in support of retracting Makena, the only treatment approved to help prevent preterm birth, from the market, which the agency fast-tracked and approved in 2011. 

With CDC data forecasting an early flu season "increasing in most of the country" and flu shot uptake lower than normal, pharmacies may be caught unprepared. 

The first trial to evaluate the long-term effects of remdesivir — Gilead Science's treatment for COVID-19, and the first one to be approved by the FDA in 2020 — found there was "no convincing evidence of remdesivir benefit" one year…

Johnson & Johnson might trim its workforce because of financial pressures and its plans to spin off its consumer health business in 2023, The Wall Street Journal reported Oct. 18. 

In a deal nearing half a billion dollars, Indianapolis-based Eli Lilly will acquire a genetic medicine company focused on hearing loss treatments, the drugmaker said Oct. 18. 

A nasal spray candidate for treating abnormal heart rhythm found "topline efficacy and safety" results in a phase 3 clinical trial, a Montreal-based biopharmaceutical company said Oct. 17.

The Health Resources and Services Administration sent letters to drugmakers AbbVie and Amgen on Oct. 17 warning that they are in violation of a federal program by overcharging drug sales.